Entry Inhibitors
Showing 1 - 25 of 5,772
HIV Trial in United States (SCH-D (vicriviroc), Placebo)
Completed
- HIV Infections
- SCH-D (vicriviroc)
- Placebo
-
Los Angeles, California
- +29 more
Oct 28, 2021
Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)
Recruiting
- Rectal Neoplasms
- Tislelizumab
- +4 more
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Aug 27, 2023
Peripartum Cardiomyopathy, Postpartum Trial in Pittsburgh (Bromocriptine, Placebo, Guideline Directed Medical Therapy for Heart
Recruiting
- Peripartum Cardiomyopathy, Postpartum
- Bromocriptine
- +4 more
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Jun 9, 2022
Chronic Hepatitis C Trial in Hines (20mg ezetimibe, Placebo, 40mg ezetimibe)
Terminated
- Chronic Hepatitis C
- 20mg ezetimibe
- +2 more
-
Hines, IllinoisEdward Hines Jr. VA Hospital, Hines, IL
May 10, 2022
Mitral Valve Insufficiency, Left Ventricular Systolic Dysfunction Trial in Seoul (Ertugliflozin, Placebo)
Recruiting
- Mitral Valve Insufficiency
- Left Ventricular Systolic Dysfunction
- Ertugliflozin
- Placebo
-
Seoul, Korea, Republic of
- +2 more
Jun 19, 2022
PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen
Not yet recruiting
- Acute Pancreatitis
- Proton pump inhibitor
- LAMS-implantation
-
St. Pölten, Niederösterreich, Austria
- +11 more
Apr 16, 2023
The Effect of RAAS Blockers on ACE2 Levels
Completed
- Renin-Angiotensin System
- ACE inhibitor ,angiotensin receptor blockers
-
Cairo, Select A State Or Province, EgyptAinshams University
Jun 10, 2022
Angiotensin Converting Enzyme Inhibitors and Angiotensin
Not yet recruiting
- COVID-19 Pneumonia
- Covid_19
- (no location specified)
Jun 5, 2022
Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)
Recruiting
- Chronic Myeloid Leukemia, Chronic Phase
- Withdrawal;Drug
- Imatinib withdrawal
- +2 more
-
Brno, Czechia
- +7 more
Aug 24, 2022
Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients
Recruiting
- Lung Neoplasms
- +3 more
- Observation
-
Shanghai, ChinaShanghai Chest Hospital
Mar 14, 2022
Post Operative Pain, Erector Spinae Plane Block, Inguinal Hernia Trial in Sisli (wound site local anesthesic infiltration,
Not yet recruiting
- Post Operative Pain
- +2 more
- wound site local anesthesic infiltration
- Erector spina plane block
-
Sisli, Istanbul, TurkeySisli Hamidiye Etfal Training and Research Hospital
Feb 4, 2023
Cancer in Patients on Dapagliflozin and Other Antidiabetic
Recruiting
- Breast Cancer
- Bladder Cancer
-
Wilmington, Delaware
- +3 more
Jan 13, 2023
HIV Trial in United States (Doravirine 100 Mg, Tenofovir alafenamide/emtricitabine, tenofovir alafenamide/lamivudine)
Recruiting
- HIV Infections
- Doravirine 100 Mg
- +5 more
-
Birmingham, Alabama
- +22 more
Feb 22, 2022
Hepatocellular Carcinoma Non-resectable, Portal Vein Tumor Thrombus, Immune Checkpoint Inhibitors Trial in Nanning (Cadonilimab,
Recruiting
- Hepatocellular Carcinoma Non-resectable
- +2 more
- Cadonilimab
- +2 more
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Sep 13, 2023
Depression Trial in Karachi (chamomile tea n saffron)
Active, not recruiting
- Depression
- chamomile tea n saffron
-
Karachi, PK, PakistanAga Khan University
Nov 16, 2022
Adherence to Drug Therapy in Patients With HFrEF Trial in Quedlinburg
Active, not recruiting
- Adherence to Drug Therapy in Patients With HFrEF
-
Quedlinburg, Saxony-Anhalt, GermanyParacelsus Harz Clinic Bad Suderode
Sep 15, 2022
Axial Spondyloarthritis Trial in Dhaka (Baricitinib 2mg, Tofacitinib 5 mg)
Recruiting
- Axial Spondyloarthritis
- Baricitinib 2mg
- Tofacitinib 5 mg
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
Nov 1, 2023
Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal
Recruiting
- Platinum-Refractory Fallopian Tube Carcinoma
- +11 more
- Copanlisib Hydrochloride
- +4 more
-
Aurora, Colorado
- +2 more
Dec 8, 2022
HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)
Fallopian Tube Endometrioid Tumor, Fallopian Tube High Grade Serous Adenocarcinoma, Malignant Ovarian Endometrioid Tumor Trial
Active, not recruiting
- Fallopian Tube Endometrioid Tumor
- +13 more
- Olaparib
- Tremelimumab
-
Orange, California
- +19 more
Jan 10, 2023